Value of pancreatic duct stent placement combined with octreotide for reducing the postoperative pancreatic fistula rate in patients with diabetes undergoing pancreaticoduodenectomy

Table 4 Occurrence of adverse reactions in the two groups of patients, n (%)

Adverse reactions	Combined group (n = 60)	Control group (n = 60)	χ²	P value
Mild diarrhea	3 (5.0)	2 (3.3)	0.210	0.647
Mild nausea	2 (3.3)	1 (1.7)	0.345	0.557
Overall incidence of adverse reactions	5 (8.3)	3 (5.0)	0.536	0.464